Valneva

Valneva Financial Leverage

The Financial Leverage (Equity Multiplier) of Valneva (VLA.PA) as of Oct 19, 2026 is 3.76. In the previous year, Financial Leverage (Equity Multiplier) was 2.76 — a change of 36.17% (higher).

Financial Leverage

3.76

YoY

36.17%

Last updated:

Financial Leverage (Equity Multiplier) of Valneva is 2025 3.76 . Financial Leverage (Equity Multiplier) of Valneva was 2024 2.76 . It decreases by 36.17% higher compared to the previous year.

The Valneva Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.61 EUR
Jan 1, 2019
1.96 EUR
Jan 1, 2020
5.80 EUR
Jan 1, 2021
4.79 EUR
Jan 1, 2022
2.83 EUR
Jan 1, 2023
3.59 EUR
Jan 1, 2024
2.76 EUR
Jan 1, 2025
3.76 EUR
The Valneva Financial Leverage history
YEARFinancial LeverageYoY
3.76+36.17%
2.76-23.10%
3.59+26.90%
2.83-41.00%
4.79-17.41%
5.80+196.19%
1.96+21.99%
1.61-21.42%
2.04-1.19%
2.07+8.45%
1.91+4.28%
1.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Financial Leverage (Equity Multiplier) of Valneva is 3.76 in 2025.

Financial Leverage (Equity Multiplier) of Valneva changed from 2.76 to 3.76, representing a 36.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Valneva since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Valneva with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Valneva

All Key Metrics — Valneva